Israel Englander Bio Cardia, Inc. Transaction History

Millennium Management LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$1.61 - $32.1 $16,114 - $321,288	-10,009 Reduced 46.46%	11,536 $24,000
Q3 2022 Nov 14, 2022	SELL	$0.24 - $30.3 $1,624 - $205,040	-6,767 Reduced 23.9%	21,545 $42,000
Q2 2022 Aug 15, 2022	BUY	$17.7 - $32.55 $501,122 - $921,555	28,312 New	28,312 $42,000
Q4 2021 Feb 14, 2022	SELL	$25.65 - $46.05 $256,884 - $461,190	-10,015 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$42.6 - $58.65 $426,639 - $587,379	10,015 New	10,015 $31,000
Q3 2020 Nov 16, 2020	SELL	$30.75 - $42.0 $530,806 - $725,004	-17,262 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$31.8 - $77.64 $474,233 - $1.16 Million	-14,913 Reduced 46.35%	17,262 $41,000
Q1 2020 May 14, 2020	SELL	$33.0 - $85.2 $858 - $2,215	-26 Reduced 0.08%	32,175 $104,000
Q4 2019 Feb 14, 2020	SELL	$48.0 - $72.0 $469,296 - $703,944	-9,777 Reduced 23.29%	32,201 $118,000
Q3 2019 Nov 14, 2019	BUY	$51.3 - $94.5 $2.15 Million - $3.97 Million	41,978 New	41,978 $138,000

Ticker BCDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 17,758,200
Market Cap $41.2M
Description
BioCardia, Inc., a clinical-stage regenerative medicine company, develops cellular and cell-derived therapeutics for cardiovascular and pulmonary diseases. Its lead therapeutic candidate is the CardiAMP Cell Therapy System for the treatment of heart failure and chronic myocardial ischemia; and allogeneic cell therapy for cardiac and pulmonary di...

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.